CNSDose

Australia
Genetic testing for personalized mental health medication is provided.
Request Access

About CNSDose

CNSDose is a company based in Australia. It operates as a HealthTech, and Direct-to-Consumer (D2C). CNSDose has completed 1 acquisition, including CNSDose. CNSDose offers products and services including CNSDose Test. CNSDose operates in a competitive market with competitors including Orchid, Immunosis, The Gene Council, Private Genetic Health and Genepath, among others.

  • Headquarter Australia
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CNSDose

CNSDose offers a comprehensive portfolio of products and services, including CNSDose Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Genetic test for personalized mental health medication guidance.

Funding Insights of CNSDose

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by CNSDose

CNSDose has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CNSDose. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Pharmacogenomics tools for anti-depressant regimens are developed.
2015
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - CNSDose

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cnsdose Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CNSDose

CNSDose operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orchid, Immunosis, The Gene Council, Private Genetic Health and Genepath, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genetic screening services are provided for embryos and couples.
domain founded_year HQ Location
Developer of a diagnostic platform for diagnosing patients with immune dysfunctions
domain founded_year HQ Location
Offers private genetic testing and counselling for cancer risk, with online appointments and expert advice.
domain founded_year HQ Location
Provides genetic counselling, testing, and education for families with health conditions.
domain founded_year HQ Location
Provides targeted gene sequencing for newborn screening and health detection.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cnsdose

Frequently Asked Questions about CNSDose

Where is CNSDose located?

CNSDose is headquartered in Australia.

What does CNSDose do?

Personalized genetic testing for mental health medication guidance is offered by CNSDose, a service under Incite Genomics. Focus is placed on analyzing 19 genes related to liver metabolism and blood-brain barrier transport to reduce trial-and-error prescribing. Solutions are provided for conditions like depression, anxiety, and ADHD, with actionable reports for clinicians and patients. The healthcare sector is primarily served, with an emphasis on pioneering neuroscience and medication avoidance alerts across psychiatry, cardiology, and other fields.

Who are the top competitors of CNSDose?

CNSDose's top competitors include Orchid, Immunosis and The Gene Council.

What products or services does CNSDose offer?

CNSDose offers CNSDose Test.

How many acquisitions has CNSDose made?

CNSDose has made 1 acquisition, including CNSDose.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available